Is red light bad for your eyes? A 488-study search
Thousands of children have had red light shone straight into their eyes for myopia. What those trials showed about safety, and where harm did happen.

How it is supposed to work
In short-sightedness the eyeball grows too long, so the image falls in front of the retina instead of on it. The proposal behind red light is that it increases blood flow in the choroid, the vascular layer behind the retina, and that a thicker choroid slows or halts that elongation.
That is a mechanical explanation for a mechanical problem, which is part of why it was taken seriously. But the same absorption that is supposed to help is the reason the safety question exists at all: the retina is the one tissue in the body designed to absorb light, and it does not repair.
The short answer
Red light straight into your eyes sounds like something you should not do. It is nonetheless exactly what has been done to thousands of children over the past few years, supervised by ophthalmologists, in randomised trials.
Not as an experiment with light, but as a treatment for myopia. And because it involved children and their retinas, a separate safety literature grew up around it. That makes this one of the few questions about light where you do not have to fall back on animal work and anecdotes: there is real human evidence.
What happened in thousands of treated children?
Myopia is rising fast worldwide, and in children the eye literally grows too long. Since around 2021 red light has been used against it: two three-minute sessions a day, the child looking into a small device emitting red light at around 650 nm.
The body of research is now substantial.
A second, independent meta-analysis landed in almost the same place: fourteen trials, 1,942 children, −0.33 mm of axial length at twelve months [2].
Then came the comparison that actually matters. A network meta-analysis set red light beside the established treatments, 0.01% atropine eye drops and overnight contact lenses (orthokeratology), across 41 trials and 6,434 eyes [3]. Every treatment worked. Red light was the most effective of them at twelve months.
That is a striking result for something sold on consumer sites mainly as a wellness product.
Is red light therapy for myopia safe?
This is the question the article turns on, and the answer is more reassuring than you might expect, with one important limit.
A separate trial looked past complaints and measured retinal function and structure directly, with mfERG in 108 children [5]. Within twelve months it found no damage. Two structural measures did change, and the authors write plainly that it is unclear what that means and that it needs following.
The limit is stated in the review itself and matters more than the reassurance: the studies ran a median of nine months, the longest two years. What happens after three, five or ten years is unknown. That is exactly the span over which somebody buys a lamp at home and keeps using it.
So the researchers do not conclude "it is safe". They recommend monitoring: retinal photographs and OCT before and during treatment, and watching at home how long the afterimage lasts.
What happens when you stop the treatment?
One trial compared red light directly against high-concentration atropine in 116 children, and then looked at what happened after stopping [6].
Red light won over twelve months. But the rebound after stopping was larger with red light than with atropine. The authors suggest tapering rather than stopping abruptly.
That pattern is familiar from almost any treatment that manages rather than cures. It is not an objection to the treatment. It is different from what an advertisement promises.
Has red light ever damaged an eye?
The reported cases of lasting eye damage do not come from these trials. They come from somewhere else, and the difference is the whole lesson.
One case report describes phototoxic maculopathy in someone who repeatedly looked straight into the tubes of a quartz infrared heat lamp. Not a therapy device: a heater. Vision partly recovered over ten months, leaving a small permanent defect [8]. A second describes real clinical injury from a laser pointer emitting hazardous levels of both visible and infrared radiation [9].
For a sense of scale: an exposure of 197 W/cm² at 1,090 nm for eight seconds raised the temperature near the retina by 26 °C and caused cataract [10]. That is roughly a thousand times more intense than consumer photobiomodulation devices, which work in milliwatts per square centimetre.
A concrete ceiling has been measured too. At 670 nm the threshold for retinal damage sat at 500 mW/cm², while 25 and 100 mW/cm² produced no adverse effect at all [7]. That is a number to design a device against, not a vague "keep it low".
One warning does belong here, and it concerns the invisible part of the spectrum. Broadband near-infrared from 1,000 to 1,800 nm, simulating sunlight, sharply increased a stress-response gene in human corneal tissue. The authors state explicitly that near-infrared radiation can cause ocular damage under intense or prolonged exposure, and that ordinary sunglasses do not adequately block this range [11]. That is a different band from the 630 to 800 nm that ocular light research concentrates on [12], and that distinction is the heart of the matter.
Is a red light lamp at home safe?
Put the two sides together and a usable rule falls out.
What proved safe in thousands of children was red light around 650 nm, in short three-minute sessions, from a device built and measured for it, under an ophthalmologist's supervision. What caused harm was prolonged, direct staring into a source never meant for it: a heat lamp, a laser pointer.
The difference is not only intensity. It is wavelength, duration, and whether the light hangs diffusely in a room or enters your pupil as a beam.
Sources
- 1.Lin LY, et al. Duration-dependent efficacy and clinical safety of repeated low-level red-light therapy for paediatric myopia: a systematic review and meta-analysis (28 RCT's, n=3.573). Clinical & Experimental Ophthalmology, 2026. PMID: 41846466↩
- 2.Liu D, et al. Efficacy of repeated low-level red-light therapy for myopia management in children and adolescents: a systematic review and meta-analysis (14 RCT's, n=1.942). BMC Ophthalmology, 2026. PMID: 41680682↩
- 3.Zheng Z, et al. Efficacy comparison of atropine, orthokeratology and repeated low-level red-light therapy for myopia control in children: a systematic review and network meta-analysis (41 RCT's, 6.434 ogen). British Journal of Ophthalmology, 2025. PMID: 40610049↩
- 4.Chen Y, et al. Safety of repeated low-level red-light therapy for myopia: a systematic review (20 studies, 2.380 deelnemers van 3 tot 18 jaar). Asia-Pacific Journal of Ophthalmology, 2024. PMID: 39672511↩
- 5.Zhu M, et al. Safety of repeated low-level red-light therapy for children with myopia (n=108, netvliesfunctie en -structuur over 12 maanden). Photodiagnosis and Photodynamic Therapy, 2024. PMID: 38729232↩
- 6.Xie J, et al. Efficacy and rebound effects of repeated low-level red light versus high-concentration atropine for myopia control in children: a randomized controlled trial (n=116). Clinical & Experimental Ophthalmology, 2026. PMID: 41796439↩
- 7.Ao J, et al. Safety profile of slit-lamp-delivered retinal laser photobiomodulation: dosis-responsonderzoek naar de drempel voor netvliesschade bij 670 nm. 2020. PMID: 32818109↩
- 8.Zheng X, et al. Phototoxic maculopathy induced by quartz infrared heat lamp: klinische casus. 2017. PMID: 28099337↩
- 9.Hanson JV, et al. Maculopathy following exposure to visible and infrared radiation from a laser pointer: klinische casus. 2016. PMID: 26921203↩
- 10.Yu Z, et al. Ocular temperature elevation induced by threshold in vivo exposure to 1090 nm infrared radiation. 2014. PMID: 25321397↩
- 11.Tanaka Y, et al. Upregulated epidermal growth factor receptor expression following near-infrared irradiation in gereconstrueerd menselijk hoornvliesweefsel. 2016. PMID: 27536083↩
- 12.Chichan H, et al. Photobiomodulation in ocular therapy: current status and future perspectives. 2025. PMID: 39967973↩

